Business
Pulsenmore Names David Woods Chief Commercial Officer in U.S. Push
The home ultrasound maker has begun U.S. commercial operations after FDA De Novo authorization and is working with Ouma Health.
Creo Medical
Business
The home ultrasound maker has begun U.S. commercial operations after FDA De Novo authorization and is working with Ouma Health.